These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals. Mahajan S; Kode V; Bhojak K; Karunakaran C; Lee K; Manoharan M; Ramesh A; Hv S; Srivastava A; Sathian R; Khan T; Kumar P; Gupta R; Chakraborty P; Chaudhuri A Sci Rep; 2021 Jun; 11(1):13164. PubMed ID: 34162945 [TBL] [Abstract][Full Text] [Related]
12. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals. Quiros-Fernandez I; Poorebrahim M; Fakhr E; Cid-Arregui A EBioMedicine; 2021 Oct; 72():103610. PubMed ID: 34627082 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects. Zhao J; Wang L; Schank M; Dang X; Lu Z; Cao D; Khanal S; Nguyen LN; Nguyen LNT; Zhang J; Zhang Y; Adkins JL; Baird EM; Wu XY; Ning S; Gazzar ME; Moorman JP; Yao ZQ Virus Res; 2021 Oct; 304():198508. PubMed ID: 34329696 [TBL] [Abstract][Full Text] [Related]
14. Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein. Chaurasia P; Nguyen THO; Rowntree LC; Juno JA; Wheatley AK; Kent SJ; Kedzierska K; Rossjohn J; Petersen J J Biol Chem; 2021 Sep; 297(3):101065. PubMed ID: 34384783 [TBL] [Abstract][Full Text] [Related]
15. Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR. Szeto C; Nguyen AT; Lobos CA; Chatzileontiadou DSM; Jayasinghe D; Grant EJ; Riboldi-Tunnicliffe A; Smith C; Gras S Cells; 2021 Oct; 10(10):. PubMed ID: 34685626 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors. Shomuradova AS; Vagida MS; Sheetikov SA; Zornikova KV; Kiryukhin D; Titov A; Peshkova IO; Khmelevskaya A; Dianov DV; Malasheva M; Shmelev A; Serdyuk Y; Bagaev DV; Pivnyuk A; Shcherbinin DS; Maleeva AV; Shakirova NT; Pilunov A; Malko DB; Khamaganova EG; Biderman B; Ivanov A; Shugay M; Efimov GA Immunity; 2020 Dec; 53(6):1245-1257.e5. PubMed ID: 33326767 [TBL] [Abstract][Full Text] [Related]
17. Structural insights into immune escape at killer T cell epitope by SARS-CoV-2 Spike Y453F variants. Deng S; Xu Z; Wang M; Hu J; Liu Z; Zhu F; Zheng P; Kombe Kombe AJ; Zhang H; Wu S; Jin T J Biol Chem; 2024 Aug; 300(8):107563. PubMed ID: 39002680 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations. Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614 [TBL] [Abstract][Full Text] [Related]
19. Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm. Boni C; Cavazzini D; Bolchi A; Rossi M; Vecchi A; Tiezzi C; Barili V; Fisicaro P; Ferrari C; Ottonello S Front Immunol; 2021; 12():730051. PubMed ID: 34566990 [TBL] [Abstract][Full Text] [Related]
20. Human CD4 Verhagen J; van der Meijden ED; Lang V; Kremer AE; Völkl S; Mackensen A; Aigner M; Kremer AN Clin Exp Immunol; 2021 Sep; 205(3):363-378. PubMed ID: 34061349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]